Oligonucleotide Services
Choose excellence, choose WuXi Biology- your reliable partner in oligonucleotide drug discovery. WuXi Biology provides an integrated service platform for support of the discovery of oligonucleotide drugs. Our services cover sequence and modification design of oligonucleotides, in vitro and in vivo biological and PK/PD evaluations, and assessment of oligonucleotide off-target effects. Our broad and deep expertise spans cross diverse oligonucleotide modalities, including siRNAs, Gapmers ASOs, splicing-switch ASOs and mRNAs. We have supported multiple projects for oligonucleotide drug discovery as well as more than 40 IND projects since 2021.
View our platform of oligonucleotide services by clicking HERE.
Advancing Discovery of Oligonucleotide Drugs
Related Content
Antibody-targeted therapies—including antibody-drug conjugates (ADCs), antibody-oligonucleotide conjugates (AOCs), and degrader-antibody conjugates (DACs)—are reshaping precision medicine by enabling highly selective delivery...
VIEW RESOURCERNA therapeutics can target specific mRNAs with high specificity, making them advantageous for treating genetic diseases caused by known mutations....
VIEW RESOURCE